10/1/2009

The FDA has cleared Covidien's Mallinckrodt TaperGuard Evac endotracheal tube, a breathing-assistance device designed for use in intensive care units and emergency rooms. The company said the new version of the device potentially could lower the risk of postsurgical complications.

Full Story:
Forbes

Related Summaries